Search results
These were the FTSE’s superstar shares in April!
Fool.co.uk via Yahoo Finance UK· 4 days agoThe FTSE has had a great month, rising over 3% in 30 days and beating the US S&P 500. But one of these superstar stocks surged by almost 41% in April!...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance UK· 4 days agoWith many pharma and biotech bigwigs having already reported results, the earnings picture has been...
Pandemic treaty will give WHO power to demand 20pc of British vaccines
Daily Telegraph· 6 days agoBritain was among the first countries to develop and roll out a Covid vaccine, the AstraZeneca jab,...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance UK· 1 day agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
3 legendary FTSE 100 dividend stocks I’d buy for passive income today
Fool.co.uk via Yahoo Finance UK· 2 days agoWith at least 30 years of continuous dividend payouts, these FTSE 100 stocks look like good choices...
£20,000 in cash? Here's how I'd aim for £10,000 in annual passive income!
Motley Fool UK· 3 days agoBecause capital gains and dividends on ISA investments are awarded tax-free treatment, it’s an...
The true tragedy of the Covid-19 vaccines
Daily Telegraph· 3 days agoIndeed, some public health officials exaggerated the benefits and underplayed some of the risks. Thrombosis caused by the AstraZeneca vaccine and...
Britain must go it alone and cut interest rates, says ALEX BRUMMER
This Is Money· 3 days agoBritain has long looked across the Atlantic for guidance on interest rates. Of all the European...
I’m not a Covid conspiracy theorist. I was right
Daily Telegraph· 2 days agoIn the unlikely event that anyone should ever need to lay their hands on a Pearson opus from 1999, they will find it neatly filed in a bungalow in...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg via Yahoo Finance UK· 1 day ago(Bloomberg) -- Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug...
